Special Issue "Editorial Board Members’ Collection Series: Image-Guided and Targeted Theranostic Platforms"
Deadline for manuscript submissions: 30 December 2023 | Viewed by 2564
Interests: cancer therapy; drug delivery; drug targeting; infectious disease; micelle; nanoparticles; nanotechnology; polymers; targeted therapies; HIV; antibody engineering; antibody–drug conjugates
Special Issues, Collections and Topics in MDPI journals
Special Issue in Scientia Pharmaceutica: Advances in Nanoparticle-Mediated Drug Delivery
Special Issue in Bioengineering: Extracellular Vesicles (EVs) in Formulation Development, Pre-clinical and Clinical Stages
Special Issue in International Journal of Molecular Sciences: Biomaterials and Their Composites for Biomedical Applications and Beyond
Interests: nano-emulsion; emulsion; nanoparticle; molecular imaging; drug delivery systems; theranostics; targeting; physicalchemistry of colloids and interfaces
We are pleased to invite you to contribute to this Special Issue on “Image-Guided and Targeted Theranostic Platforms” in the medical field. This Special Issue intends to provide a unique collection of the latest research accomplishments in the field of imaging, diagnosis, therapy, and nanotheranostics.
Nanotechnology has offered new avenues in the development of new imaging, diagnostic, and targeted therapeutic formulations that target a number of diseases, including cancer. Nanoparticle-mediated delivery of therapeutics and biological agents has been documented in the literature and a recent example is the COVID-19 vaccines (liposomal formulations). Over 100 nanotechnology-based formulations are in clinical use for various indications. However, there are still challenges associated with unique imaging, tracing, and theranostic techniques for the areas of the body that are more difficult to reach. In this regard, we seek novel formulations that are well-suited to drug/contrast/biomacromolecular delivery and their potential modifications and functionalization for targeted accumulation and therapeutic benefits. Image-guided therapeutic delivery is a new concept that combines the effect of therapy and visibility aspects into one single system to overcome the conventional limitations that exist in nanotechnology. These targeted nanoformulations with a variety of medical imaging tracking capability approaches can develop “see and treat” technologies for site-specific treatment in a minimally invasive way, for effective management of various diseases.
In this Special Issue, original research articles and reviews are welcome. Research areas may include, but are not limited to, recent advances in novel nanoparticle constructs, drug-delivery, imaging, and theranostic applications. This Special Issue also covers smart biocompatible/biodegradable theranostics, metal-based nanoformulations, medical imaging tracking modalities, and imaging applied in the drug-delivery field. Moreover, we also encourage research on the aspects of applied characterization, toxicity, and site/disease-specific or multi-modal contrast agents.
Dr. Murali Mohan Yallapu
Dr. Nicolas Anton
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- multimodal imaging
- combined therapies
- tumor targeting
- metallic nanoparticles
- multi-component nanoparticles
- medical imaging
- drug delivery
- nano imaging agents